Petclav 250

Petclav is stable in the presence of gastric acid and is not significantly influenced by gastric or intestinal contents. The two components are rapidly absorbed, resulting in amoxicillin and clavulanic acid concentrations in serum, urine, and tissue similar to those produced when each is administered alone.
Petclav diffuses readily into most body tissues and fluids, with the exception of the brain and spinal fluid, which amoxicillin penetrates adequately when meninges are inflamed.
Petclav combines the distinctive properties of a broad-spectrum antibiotic and a beta-lactamase inhibitor to effectively extend the antibacterial spectrum of amoxicillin to include beta-lactamase-producing aerobic and anaerobic organisms.
Petclav has been shown to have broad-spectrum activity, including beta-lactamase-producing strains of both Gram-negative and Gram-positive aerobes, facultative anaerobes, and obligate anaerobes.

Petclav is orally administered to effectively treat:
Skin infections
Periodontal infections
Urinary tract infections

Dosage and Administration:
Dogs: The recommended dosage of Petclav Tablet is 13.75 mg/kg of body weight twice a day.
Skin and soft tissue infections such as abscesses, cellulitis, wounds, superficial/juvenile pyoderma, and periodontal infections should be treated for 5–7 days or for 48 hours after all symptoms have subsided.
Deep pyoderma may require treatment for 21 days. The maximum duration of treatment should not exceed 30 days.
Urinary tract infections may require treatment for 10–14 days or longer. The maximum duration of treatment should not exceed 30 days.

Directions for Use
Use as prescribed by the doctor.

Precautions
N/A